Total Payments
$11,692
2024 Payments
$2,495
Companies
49
Transactions
884
Medicare Patients
5,161
Medicare Billing
$166,739
Payment Breakdown by Category
Food & Beverage$11,678 (99.9%)
Education$13.69 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,678 | 882 | 99.9% |
| Education | $13.69 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,008 | 175 | $0 (2024) |
| Lilly USA, LLC | $1,165 | 95 | $0 (2024) |
| PFIZER INC. | $1,052 | 88 | $0 (2024) |
| Novo Nordisk Inc | $975.48 | 90 | $0 (2024) |
| GlaxoSmithKline, LLC. | $807.67 | 54 | $0 (2024) |
| Amgen Inc. | $607.90 | 45 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $549.67 | 26 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $472.59 | 31 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $407.88 | 30 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $401.89 | 23 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,495 | 197 | ABBVIE INC. ($486.51) |
| 2023 | $3,075 | 214 | ABBVIE INC. ($547.33) |
| 2022 | $2,869 | 221 | ABBVIE INC. ($423.60) |
| 2021 | $3,253 | 252 | AbbVie Inc. ($550.99) |
All Payment Transactions
884 individual payment records from CMS Open Payments — Page 3 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/28/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | Lilly USA, LLC | JARDIANCE (Drug), KISUNLA, ZEPBOUND | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: Diabetes | ||||||
| 08/19/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: ANTIBIOTIC | ||||||
| 08/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.68 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: PAIN | ||||||
| 08/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $4.75 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/12/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Obesity | ||||||
| 08/07/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $10.11 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $8.49 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: PAIN | ||||||
| 07/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: RESPIRATORY | ||||||
| 07/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Diabetes | ||||||
| 07/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: Diabetes | ||||||
| 07/24/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.99 | General |
| Category: Cardiovascular | ||||||
| 07/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $10.22 | General |
| Category: Diabetes | ||||||
| 07/22/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.66 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $3.94 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.98 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 1,412 | 1,846 | $143,281 | $48,137 |
| 2022 | 33 | 1,383 | 1,807 | $130,629 | $47,384 |
| 2021 | 27 | 1,180 | 1,363 | $113,923 | $42,529 |
| 2020 | 26 | 1,186 | 1,441 | $93,313 | $28,689 |
Total Patients
5,161
Total Services
6,457
Medicare Billing
$166,739
Procedure Codes
120
All Medicare Procedures & Services
120 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 155 | 228 | $52,440 | $15,254 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 170 | 230 | $36,340 | $11,485 | 31.6% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2023 | 30 | 30 | $6,132 | $4,054 | 66.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 22 | 22 | $10,472 | $2,861 | 27.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 12 | $4,212 | $1,530 | 36.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 133 | 175 | $2,368 | $1,440 | 60.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 75 | 86 | $3,440 | $1,416 | 41.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 108 | 131 | $2,751 | $1,356 | 49.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 109 | 132 | $2,508 | $1,005 | 40.1% |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | Office | 2023 | 19 | 19 | $1,520 | $862.98 | 56.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 35 | 40 | $3,280 | $750.97 | 22.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 25 | 25 | $1,725 | $725.25 | 42.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 48 | 53 | $1,696 | $695.36 | 41.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 47 | 54 | $1,242 | $514.08 | 41.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 12 | 15 | $1,920 | $498.00 | 25.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 15 | 15 | $705.00 | $426.60 | 60.5% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 24 | 28 | $896.00 | $374.08 | 41.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 33 | 44 | $2,552 | $352.00 | 13.8% |
| 84466 | Transferrin (iron binding protein) level | Office | 2023 | 24 | 27 | $810.00 | $337.50 | 41.7% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 15 | 15 | $645.00 | $283.80 | 44.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 17 | 19 | $684.00 | $280.82 | 41.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 76 | 93 | $558.00 | $204.60 | 36.7% |
| 82746 | Folic acid level, serum | Office | 2023 | 13 | 13 | $455.00 | $187.33 | 41.2% |
| 83540 | Iron level | Office | 2023 | 24 | 27 | $432.00 | $171.18 | 39.6% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 16 | 19 | $323.00 | $157.51 | 48.8% |
About Casey Larue, FNP
Casey Larue, FNP is a Family healthcare provider based in Knoxville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1104025105.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Casey Larue, FNP has received a total of $11,692 in payments from pharmaceutical and medical device companies, with $2,495 received in 2024. These payments were reported across 884 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($11,678).
As a Medicare-enrolled provider, Larue has provided services to 5,161 Medicare beneficiaries, totaling 6,457 services with total Medicare billing of $166,739. Data is available for 4 years (2020–2023), covering 120 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Knoxville, TN
- Active Since 07/11/2007
- Last Updated 02/22/2011
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1104025105
Products in Payments
- NURTEC ODT (Drug) $1,037
- VRAYLAR (Drug) $723.54
- TRELEGY ELLIPTA (Drug) $655.61
- UBRELVY (Drug) $644.54
- ELIQUIS (Drug) $606.95
- Ozempic (Drug) $528.56
- JARDIANCE (Drug) $480.32
- REXULTI (Drug) $446.07
- XIFAXAN (Drug) $407.88
- FARXIGA (Drug) $395.41
- MOUNJARO (Drug) $368.01
- EMGALITY (Drug) $353.48
- LEQVIO (Drug) $333.96
- Otezla (Drug) $324.20
- Kerendia (Drug) $294.17
- QULIPTA (Drug) $292.37
- TRULICITY (Drug) $240.65
- Rybelsus (Drug) $237.56
- NEXLETOL (Drug) $218.43
- Vascepa (Drug) $199.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Knoxville
Karen Roden, Fnp, FNP
Family — Payments: $196,458
Family $196,458
Mrs. Tiffany Sipe, Fnp-Bc, FNP-BC
Family — Payments: $77,018
Family $77,018
Mrs. Ashley Bonnell, Fn-P, FN-P
Family — Payments: $40,051
Family $40,051
Stacey Maltman, Fnp-Bc, FNP-BC
Family — Payments: $21,528
Family $21,528
Mrs. Mina Farrar, Np, NP
Family — Payments: $19,391
Family $19,391
Ashley Bell, Fnp, FNP
Family — Payments: $17,618
Family $17,618